216 related articles for article (PubMed ID: 7231652)
1. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
Raft D; Davidson J; Wasik J; Mattox A
Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
[TBL] [Abstract][Full Text] [Related]
2. MAO inhibition and clinical response in depressed patients treated with phenelzine.
Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
[TBL] [Abstract][Full Text] [Related]
3. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
[TBL] [Abstract][Full Text] [Related]
4. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Georgotas A; McCue RE; Friedman E; Cooper T
Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of phenelzine.
Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
[TBL] [Abstract][Full Text] [Related]
8. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
Davidson J; McLeod MN; White HL
Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
[TBL] [Abstract][Full Text] [Related]
10. Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies.
Ravaris CL; Robinson DS; Ives JO; Nies A; Bartlett D
Arch Gen Psychiatry; 1980 Sep; 37(9):1075-80. PubMed ID: 7416907
[TBL] [Abstract][Full Text] [Related]
11. Phenelzine v imipramine in atypical depression. A preliminary report.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
[TBL] [Abstract][Full Text] [Related]
12. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
Stewart JW; Harrison W; Cooper TB; Quitkin FM
Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
[TBL] [Abstract][Full Text] [Related]
13. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
Georgotas A; Mann J; Friedman E
Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
[No Abstract] [Full Text] [Related]
14. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
[TBL] [Abstract][Full Text] [Related]
16. Response to phenelzine among depressed patients with features of hysteroid dysphoria.
Kayser A; Robinson DS; Nies A; Howard D
Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817
[TBL] [Abstract][Full Text] [Related]
17. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression.
Davidson J; McLeod M; Law-Yone B; Linnoila M
Arch Gen Psychiatry; 1978 May; 35(5):639-42. PubMed ID: 727903
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
[TBL] [Abstract][Full Text] [Related]
19. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
Paykel ES; Rowan PR; Parker RR; Bhat AV
Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
[TBL] [Abstract][Full Text] [Related]
20. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
Davidson J; McLeod MN; Blum MR
Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]